Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_assertion type Assertion NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_head.
- NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_assertion description "[The molecular biology of these GIST, originally defined as KIT/PDGFRA wild-type (WT), is complex due to the existence of different subgroups with distinct molecular hallmarks, including defects in the succinate dehydrogenase (SDH) complex and mutations of neurofibromatosis type 1 (NF1), BRAF, or KRAS genes (RAS-pathway or RAS-P).In this extremely heterogeneous landscape, the clinical profile and molecular abnormalities of the small subgroup of WT GIST suitably referred to as quadruple wild-type GIST (quadrupleWT or KITWT/PDGFRAWT/SDHWT/RAS-PWT) remains undefined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_provenance.
- NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_assertion evidence source_evidence_literature NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_provenance.
- NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_assertion SIO_000772 25239601 NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_provenance.
- NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_assertion wasDerivedFrom befree-2016 NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_provenance.
- NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_assertion wasGeneratedBy ECO_0000203 NP1222049.RAh2i_bBXXd8PmHoKH1m3a7V9FRYYXQPoX_mO1SaY0IEQ130_provenance.